United States · 
What does Jazz Venture Partners invest in?
Jazz Venture Partners invests most often at Series B and Series A (80% of the rounds on record), in sectors such as Technology, Science and Human Performance.
Jazz Venture Partners highlights
- 01
11 rounds on record
- 02
Mostly Series B and Series A: 80% of its rounds
- 03
Led 1 rounds
- 04
1 exits from the portfolio
What they do
JAZZ seeks breakthroughs at the convergence of technology, science, and humanity, improving how we live, work, and experience the world.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $20M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- TechnologyScienceHuman Performance
- Based in
- San Francisco, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first11 appearances
- 2023
1 round
- Jul
- 2019
2 rounds
- Oct
- Aug
- 2018
4 rounds
- Sept
- May
- Jan
- Jan
- 2017
3 rounds
- Sept
- May
- Jan
- 2015
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
ADAndrew David FirlikManaging DirectoriFiling they signed
JBJohn Byron SpinaleManaging DirectoriFiling they signed
JFJohn Frederick HarrisManaging DirectoriFiling they signed
ZLZach LynchManaging DirectoriFiling they signed
ZJZachary Joseph LynchManaging MemberiForm ADV
ZLZack LynchManaging DirectoriFiling they signed
We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.1Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- JAZZ Venture Partners, LLC
- SEC number
- CRD 277092
What they claim to have backed
From their own portfolio page (on their website)
35 of 47 we have independently watched raise
Akili InteractiveAllStripesAppliedVRBonito BiosciencesCadence NeuroscienceColossalEternalForm BioFreeleticsGenesis Molecular AIHalo NeuroscienceHerMDHumanCo builds productsMagic Mind providesMagnus MedicalMercaso develops softwareOuraOutsidePicnicHealth collects, digitizes,RekenRobust AISwingThrive AI HealthThrive Global providesTomato AITranscripta leverages cutting-edgeTwo BitWoebotYumi delivers scientificallyZus Healthaugmentcountjob getjustpointleagueArrive HealthEnveda Biosciences leveragesEvolv leverages molecularForesight augments humanInsight TimerKLOwenMozilla FirefoxPinpoint Predictive leveragesSounding BoardWisdo connectsmerly aisett
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
EyefluenceBought by GoogleUndisclosedOct 2016
An exit counts when it came after the firm's first round in the company. From historical deal records.